ProKidney Corp. (PROK) financial statements and ratios from SEC XBRL: revenue $893000.00 (TTM), net margin -7725.2%, revenue growth -32.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $893000.00 |
| Net Margin | -7725.2% |
| Revenue Growth (YoY) | -32.1% |
| FCF Growth (YoY) | 28.0% |
| Price / Sales | 121.88 |
| FCF Yield | -160.2% |
| Altman Z-Score | -5.98 (distress) |
| Sector P/E (Healthcare) | 21.7 |
PROK overview · PROK earnings · PROK KPIs · PROK investor relations · PROK ownership · PROK peers · PROK filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.